Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 2,718

Got OCD; check your genes for a mutation.

A new Northwestern Medicine study found evidence suggesting how neural dysfunction in a certain region of the brain can lead to obsessive and repetitive behaviors much like obsessive-compulsive disorder (OCD).

Both in humans and in mice, there is a circuit in the brain called the corticostriatal connection that regulates habitual and repetitive actions. The study found certain synaptic receptors are important for the development of this brain circuit. If these receptors are eliminated in mice, they exhibit obsessive behavior, such as over-grooming.

Read more

View article as PDF

In recent years, we have dramatically changed our view of human genome, from a collection of DNA base pairs that was largely quite stable to one whose very structure can change. We’ve learned that higher-order structural features, such as specific configurations of repeated base pair sequences, can predispose for DNA rearrangements.

One of the most intriguing types of DNA rearrangements is copy-number variants (CNVs), deletions or duplications of parts of the genome. While CNVs range in size from a few hundred base pairs to several mega-bases affecting the copy number of one to dozens of juxtaposed genes, they are not identifiable by conventional light microscopy. It was not until a few years ago that improved technology enabled us to perform high-resolution genome-wide surveys of CNVs in individual genomes. These surveys revealed a large amount of copy number variation (at least 12,000 CNVs overlapping more than 1,000 genes), most of which represent benign polymorphic changes. CNVs are classified as rare (occurring at a frequency of 1 percent in the population) or common; collectively they cover at least 12–13 percent of the genome in the general population.

Read more

The Methuselah Foundation wants to extend healthy life — By advancing tissue engineering and regenerative medicine, they want to create a world where 90-year olds can be as healthy as 50-year olds—by 2030.

Donate to the Methuselah Foundation here at this link

Methuselah Foundation reviewed the progress they made over the past year. Much of what you’ll read in this year in review letter is very late-breaking, and leads us to believe that 2017 will be a very important year in medical developments. 2016 took us a broad step closer to fulfilling our mission statement to “Make 90 the New 50, by 2030”. Why can we say that? For starters, let’s look at several achievements to date that made this year so successful:

Read more

Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm

Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.

“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”

HIV-1 infection afflicts more than 35 million people worldwide. For individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. The only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation from a graft that carried the HIV-resistant CCR5-Delta32 homozygous mutation. The patient has remained without any evidence of HIV infection for more than 8 years after discontinuation of antiretroviral drug therapy.

However, identifying immune matched adult CCR5- Delta32 homozygous donors for a given patients is not readily feasible in part because the prevalence is in only about 0.8%–1% of individuals of northern European descent and much less in other ethnic groups, as well as the fact that for such transplants with adult cells there needs to be a very close HLA match between donor and patient.

In contrast, cord blood that is CCR5- Delta32 homozygous provides a major advantage in that much less stringent HLA matching is required between donor and patient. However, a technological method to cost effectively and industrially scale the production of such cells has been missing.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Mr. Paul Collier, Managing Director of SC21 Biotech. “The ability to apply Bioquark’s cellular reprogramming tools in order to produce industrial quantities of such precious cell lines will offer a much greater global penetration of this important therapeutic modality for HIV.”

“Bioquark has spent several years studying the evolutionarily perfected ability of bioactive moieties found in ooplasms to turn back biological time and re-set cellular regulatory state” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This unique initiative is one more step in our broad translation of such natural capabilities to control the progression of human diseases.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About SC21 Biotech

SC21 Biotech is a novel a biotechnology company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

A new and extensive interview I did at New Atlas, including ideas about my #libertarian California Governor run. Libertarianism has many good ideas, but two core concepts are the non-aggression principle (NAP) and protection of private property rights—both of which I believe can be philosophically applied to the human body (and the body’s inevitable transhuman destiny of overcoming disease and decay with science and technology):

Zoltan Istvan is a transhumanist, journalist, politician, writer and libertarian. He is also running for Governor of California for the Libertarian Party on a platform pushing science and technology to the forefront of political discourse. In recent years, the movement of transhumanism has moved from a niche collection of philosophical ideals and anarcho-punk gestures into a mainstream political movement. Istvan has become the popular face of this movement after running for president in 2016 on a dedicated transhumanist platform.

We caught up with Istvan to chat about how transhumanist ideals can translate into politics, how technology is going to change us as humans and the dangers in not keeping up with new innovations, such as genetic editing.

New Atlas: How does transhumanism intersect with politics?

Istvan: For me you can never make any headway in the universe, or on planet Earth, if you don’t involve politics because so much money for innovation or research and development comes from the government and so many laws about what you can do. Genetic editing, chip implants, can you get a brain implant that makes you smarter than other people? These things are often directed by the government determining whether it’s illegal or not. You can either be thrown in jail or not thrown in jail – so you must have a political footprint, you must have attorneys on the ground, you must have that kind of legal position that can explain things in terms that a government will understand.

Read more

Don’t be the CIO that sees their own this market as most Healthcare CIO’s will not allowed to stay given they are now a brand liability not to mention all those lawsuits that are coming from lawyers of the patients.

Electronic health record databases proving to be some of the most lucrative stolen data sets in cybercrime underground.

Medical insurance identification, medical profiles, and even complete electronic health record (EHR) databases have attracted the eyes of enterprising black hats, who increasingly see EHR-related documents as some of the hottest commodities peddled in the criminal underground. A new report today shows that complete EHR databases can fetch as much as $500,000 on the Deep Web, and attackers are also making their money off of smaller caches of farmed medical identities, medical insurance ID card information, and personal medical profiles.

The data comes by way of a report from Trend Micro’s TrendLabs Forward-Looking Threat Research (FTR) Team, which took a comprehensive look at how attackers are taking advantage of healthcare organizations’ weaknesses to devastating effect. Cybercriminals always have their eyes open for new profitable revenue streams, and the poor security around increasingly data-rich EHR systems pose a huge opportunity for the bad guys.

Read more

Why not as we will see we will indeed require cell circuited technology for QBS to be full effective/ enhanced.

The TV commercial is nearly 20 years old but I remember it vividly: a couple is driving down a street when they suddenly realize the music on their tape deck is in sync with the repetitive activity on the street. From the guy casually dribbling a basketball to people walking along the sidewalk to the delivery people passing packages out of their truck, everything and everyone is moving rhythmically to the beat.

The ending tag line was, “Sometimes things just come together,” which is quite true. Many of our basic daily activities like breathing and walking just come together as a result of repetitive movement. It’s easy to take them for granted but those rhythmic patterns ultimately rely on very intricate, interconnected signals between nerve cells, also called neurons, in the brain and spinal cord.

Read more

Researchers at the University of Eindhoven in the Netherlands have developed a DNA computer that can respond to the presence of specific antibodies and make calculations, with the potential for intelligent drug delivery in the future. DNA computing involves using DNA molecules and other molecular biological components as molecular circuitry, instead of traditional silicon-based circuitry in computer devices. The DNA sequence dictates which other DNA molecules a DNA strand can interact with, allowing researchers to program DNA circuitry.

Scientists have been trying to use DNA computing as a method to detect biomarkers of disease in the body. Using this technique, a DNA computer could make calculations and perform a specific function, such as release a drug or activate an enzyme, in response to biological stimuli such as disease biomarkers.

So far, the inputs of DNA computers have been other DNA or RNA molecules, which has limited their usefulness as diagnostic or therapeutic systems. However, in this study, published in Nature Communications, scientists have developed a DNA computer that can respond to multiple antibody inputs and perform calculations to formulate an appropriate response. Antibodies are biomarkers in a variety of diseases, meaning that the new system has significant potential as an intelligent drug delivery system. The system translates the presence of an antibody into a DNA strand, that can then interact with other DNA strands in the molecular circuitry in calculating the appropriate response.

Read more

Restorative neuroscience, the study to identify means to replace damaged neurons and recover permanently lost mental or physical abilities, is a rapidly advancing scientific field considering our progressively aging society. Redirecting immature neurons that reside in specific brain areas towards the sites of brain damage is an appealing strategy for the therapy of acute brain injury or stroke. A collaborative effort between the Center for Brain Research of Medical University of Vienna and the National Brain Research Program of Hungary/Semmelweis University in Budapest revealed that some mature neurons are able to reconfigure their local microenvironment such that it becomes conducive for adult-born immature neurons to extensively migrate. Thus, a molecular principle emerges that can allow researchers to best mobilize resident cellular reserves in the adult brain and guide immature neurons to the sites of brain damage.

The adult brain has limited capacity of self-repair.

In the aging Western society, acute brain damage and chronic neurodegenerative conditions (e.g. Alzheimer’s and Parkinson’s diseases) are amongst the most debilitating diseases affecting hundreds of millions of people world-wide. Nerve cells are particularly sensitive to microenvironmental insults and their loss clearly manifests as neurological deficit. Since the innate ability of the adult human brain to regenerate is very poor and confined to its few specialized regions, a key question in present-day neurobiology is how to establish efficient strategies that can replace lost neurons, guide competent cells to the sites of injury and facilitate their functional integration to regain lost functionality. “Cell replacement therapy” thus offers frontline opportunities to design potent therapeutic interventions.

Read more